VCEL
#1972
Vericel Corporation - Common Stock
40.9 5 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.56%
Variación mensual
-12.82%
Variación en los últimos 6 meses
+18.52%
Cambio anual
+12.65%
Cierres anteriores
41.1 8
Open
40.9 6
Mínimo
40.9 5
Máximo
40.9 6
Volumen
75
Financials
- Market Capitalization 2.1 B
- Employee 398
- Founded 1989
- CEO Nick Colangelo
- Website www.vcel.com
- Headquarter Michigan, United States
- FIGI BBG000BDCM24
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
92.69
Relación precio/flujo de caja
7.53
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1948 |  AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.29 USD | -1.15% | -1.69% | +10.07% | +36.55% | 2.17 B USD | ||
| 1961 |  URGN UroGen Pharma Ltd. - Ordinary Shares | 43.62 USD | -4.13% | -6.76% | +6.13% | +129.58% | 2.13 B USD | ||
| 1975 |  ADMA ADMA Biologics Inc - Common Stock | 9.34 USD | -1.48% | -4.69% | +8.73% | -45.35% | 2.09 B USD | ||
| 1994 |  STOK Stoke Therapeutics, Inc. - Common Stock | 31.62 USD | -2.98% | -2.07% | +6.29% | +59.78% | 2.04 B USD |